Ekaterina Malievskaia

Recorded in the supplied dataset as E. Malievskaia, the researcher’s full given name was not available in the provided records. Malievskaia has been involved in multiple aspects of contemporary psilocybin research, with a particular focus on the clinical and operational components of therapeutic trials. Key contributions in the dataset include authorship or participation in work on the Compass Psychological Support Model for COMP360 psilocybin treatment, the development and evaluation of a therapist training programme for psilocybin therapy in treatment‑resistant depression, and roles in both acute single‑dose clinical trials and long‑term observational follow‑up studies assessing outcomes after psilocybin administration.

Her work spans early‑phase experimental studies in healthy volunteers assessing cognitive and emotional effects of psilocybin through to applied clinical research in major depressive disorder and anxiety comorbidity. Across these projects Malievskaia has contributed to standardising psychological support procedures, designing therapist training curricula suitable for clinical research settings, and operationalising trial procedures for administration, preparation and follow‑up. These activities position her at the interface of clinical implementation, trial methodology and therapeutic training within modern psychedelic psychiatry.